XENON PHARMACEUTICALS INC's ticker is XENE and the CUSIP is 98420N105. A total of 131 filers reported holding XENON PHARMACEUTICALS INC in Q4 2021. The put-call ratio across all filers is 1.02 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $102,607,998 | -11.8% | 3,003,747 | -0.6% | 0.76% | +29.5% |
| Q2 2023 | $116,349,734 | +7.8% | 3,022,071 | +0.2% | 0.59% | -16.3% |
| Q1 2023 | $107,971,916 | -10.1% | 3,016,818 | -1.0% | 0.70% | -26.8% |
| Q4 2022 | $120,098,812 | +24.9% | 3,045,874 | +14.4% | 0.96% | +56.4% |
| Q3 2022 | $96,124,000 | +24.4% | 2,662,722 | +4.8% | 0.61% | +34.8% |
| Q2 2022 | $77,269,000 | +15.4% | 2,540,059 | +16.0% | 0.45% | +50.3% |
| Q1 2022 | $66,950,000 | +27.0% | 2,190,059 | +29.7% | 0.30% | +52.5% |
| Q4 2021 | $52,734,000 | – | 1,688,044 | – | 0.20% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Ally Bridge Group (NY) LLC | 266,961 | $9,119,388 | 10.70% |
| COMMODORE CAPITAL LP | 1,845,000 | $63,025,200 | 7.37% |
| TLS Advisors LLC | 32,956 | $1,126 | 4.56% |
| Altium Capital Management LP | 228,000 | $7,788,480 | 4.06% |
| Paradigm Biocapital Advisors LP | 1,491,835 | $50,961,084 | 3.46% |
| GREAT POINT PARTNERS LLC | 500,001 | $17,080,034 | 3.11% |
| DAFNA Capital Management LLC | 280,538 | $9,583,178 | 2.98% |
| Nan Fung Group Holdings Ltd | 106,680 | $3,644,189 | 2.95% |
| Affinity Asset Advisors, LLC | 300,438 | $10,262,962 | 2.89% |
| Avoro Capital Advisors LLC | 4,900,000 | $167,384,000 | 2.61% |